CRISIL Issues QIP Monitoring Report for Poly Medicure's September Quarter
Poly Medicure Ltd 路 Others (Uncategorized) 路 07 Nov 2026, 8:00 pm
CRISIL Issues QIP Monitoring Report for Poly Medicure's September Quarter CRISIL Ratings released its Monitoring Agency Report for Poly Medicure Limited for the quarter ended 30th Sep'26 regarding its Rs 99,999.98 lakh QIP. Cumulative proceeds utilized reached Rs 58,105.83 lakh, leaving Rs 40,428.54 lakh unutilized and deployed in mutual funds, bonds, and bank deposits. The company has fully utilized allocations for inorganic initiatives (Rs 25,026.84 lakh) and general corporate purposes (Rs 23,534.37 lakh). Capex deployment faced delays due to a revised execution plan shifting facility location from SEZ Jaipur to Yamuna Expressway, rescheduling capex to FY27 and FY28.
Original exchange filing (PDF)
More announcements from Poly Medicure Ltd
- Enclosed 路 13 Nov 2026
- Enclosed 路 11 Nov 2026
- Please find enclosed herewith intimation of revision of policies and/or code of conduct of the company 路 05 Nov 2026
- Please find enclose statement of deviation(s) or variation(s). 路 05 Nov 2026
- Please find enclosed herewith Investor Presentation 路 05 Nov 2026
- Enclosed 路 05 Nov 2026
- Please find enclosed outcome of the board meeting. 路 05 Nov 2026
- Poly Medicure Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 05 Nov 2026
